BNP PARIBAS FINANCIAL MARKETS - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 302 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$2,586,102,000
-94.4%
14,965
-96.3%
0.01%
-95.7%
Q4 2014$45,901,634,000
+305.3%
399,353
+451.0%
0.16%
+1530.0%
Q3 2014$11,324,429,000
-35.9%
72,481
-49.4%
0.01%
-41.2%
Q2 2014$17,680,248,000
-13.2%
143,334
-22.6%
0.02%
+6.2%
Q1 2014$20,379,300,000
-98.3%
185,266
-97.8%
0.02%
-96.4%
Q4 2013$1,214,162,400,000
+10937.5%
8,241,076
+4910.4%
0.44%
+5437.5%
Q3 2013$11,000,300,000
-9.1%
164,478
-10.1%
0.01%
-11.1%
Q2 2013$12,102,100,000182,9500.01%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 300,000$46,872,00024.29%
HealthCor Management, L.P. 935,100$146,100,0007.50%
1492 Capital Management LLC 70,167$10,963,0006.07%
Visium Asset Management, LP 2,301,629$359,607,0005.31%
HWG Holdings LP 39,621$6,190,0004.97%
Riggs Asset Managment Co. Inc. 45,649$7,132,0004.14%
Cardinal Capital Management 49,139$7,677,0003.65%
AMI ASSET MANAGEMENT CORP 213,398$33,341,0003.27%
BENNETT LAWRENCE MANAGEMENT L L C/NY 88,435$13,817,0003.14%
Adamant Biomedical Investments AG 78,210$12,220,0003.05%
View complete list of SALIX PHARMACEUTICALS INC shareholders